Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar (CELESTIAL)
CELESTIAL Post Approval Registry: Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar Post Approval Registry
Sponsor: Biotronik, Inc.
This observational or N/A phase trial investigates Congestive Heart Failure and is currently completed. Biotronik, Inc. leads this study, which shows 16 recorded versions since 2008 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
16 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Dec 2019 — Jan 2021 [monthly]
Completed
▶ Show 11 earlier versions
-
Jan 2019 — Dec 2019 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Nov 2018 — Jan 2019 [monthly]
Active Not Recruiting
-
Oct 2018 — Nov 2018 [monthly]
Active Not Recruiting
-
Sep 2018 — Oct 2018 [monthly]
Active Not Recruiting
-
Aug 2018 — Sep 2018 [monthly]
Active Not Recruiting
-
Jul 2018 — Aug 2018 [monthly]
Active Not Recruiting
-
Jun 2018 — Jul 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Jul 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
-
Feb 2017 — Jul 2017 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting NA
First recorded
Dec 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Biotronik, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .